rs1131692215
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM1PM2PM4_SupportingPP5_Moderate
The NM_000527.5(LDLR):c.1738_1739insTGT(p.Asp579_Ser580insLeu) variant causes a disruptive inframe insertion change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
 Genomes: not found (cov: 32) 
Consequence
 LDLR
NM_000527.5 disruptive_inframe_insertion
NM_000527.5 disruptive_inframe_insertion
Scores
 Not classified 
Clinical Significance
Conservation
 PhyloP100:  5.06  
Publications
0 publications found 
Genes affected
 LDLR  (HGNC:6547):  (low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022] 
LDLR Gene-Disease associations (from GenCC):
- hypercholesterolemia, familial, 1Inheritance: AD, SD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen
- homozygous familial hypercholesterolemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
PM1
In a hotspot region, there are  30 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 12 uncertain in NM_000527.5
PM2
Very rare variant in population databases, with high coverage; 
PM4
Nonframeshift variant in NON repetitive region in NM_000527.5. Strenght limited to Supporting due to length of the change: 1aa.
PP5
Variant 19-11116890-C-CTTG is Pathogenic according to our data. Variant chr19-11116890-C-CTTG is described in ClinVar as Pathogenic. ClinVar VariationId is 430785.Status of the report is criteria_provided_single_submitter, 1 stars. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| LDLR | NM_000527.5 | c.1738_1739insTGT | p.Asp579_Ser580insLeu | disruptive_inframe_insertion | Exon 12 of 18 | ENST00000558518.6 | NP_000518.1 | 
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD3 genomes 
Cov.: 
32
GnomAD4 exome Cov.: 35 
GnomAD4 exome 
Cov.: 
35
GnomAD4 genome  
GnomAD4 genome 
Cov.: 
32
ClinVar
Significance: Pathogenic 
Submissions summary: Pathogenic:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Hypercholesterolemia, familial, 1    Pathogenic:1 
Mar 30, 2017
U4M - Lille University & CHRU Lille, Université de Lille - CHRU de Lille
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 PhyloP100 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.